Purchase Order 75N93021P01305

Award Date 9/3/21
Potential Completion Date 4/30/22
Potential Value $781K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The contract is for in vitro assessment services under the In Vitro Antimicrobial Assessments IDIQ contract, which runs from 2011 to 2018. The contract has a ceiling value of $522,000.00 and was awarded on a firm fixed price basis. The place of...
This is a $18,576,013.05 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to the nonprofit research institute Access To Advanced Health Institute (AAHI), also known as Aahi, Idri, and Infectious Disease Research Institute. The contract is for the development of vaccine candidates for biodefense, antimicrobial resistant (AMR) infections, and emerging infectious...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $63,336 firm fixed price delivery order against the Nonclinical Services for Development of Interventional Agents master IDIQ to Sri International. The order is for nonclinical services to support the development of interventional agents for infectious diseases. Performance will take place in West Menlo Park, California over a one year period ending December...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $638,080 contract is for in vitro assessment of antimicrobial activity, under the In Vitro Antimicrobial Assessments 2011-2018 master IDIQ contract. The period of performance is from November 4, 2016 to October 31, 2017. AAHI is a prime contractor experienced in...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The $55,936.00 cost-plus-fixed-fee contract is a delivery order under IAVI's IDIQ contract with NIAID for preclinical services supporting biopharmaceutical product development and vaccine development for HIV and other infectious diseases. The award...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, to the Institute for Defense Analyses (IDA), a nonprofit organization that operates Federally Funded Research and Development Centers (FFRDCs). The contract, valued at $80,237.08, is for AIDS research management and support services. It is a delivery order contract with a cost-plus-fixed-fee pricing type, without any set-aside designation....
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute in Seattle, Washington. The contract is for in vitro characterization of anti-mycobacterial activity, as part of the larger In Vitro Antimicrobial Assessments 2011-2018 contract vehicle. The contract has a ceiling value of...
This federal contract award, valued at $3,170,861.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization focused on the development of HIV vaccines. The contract provides for coordination and technical support services to advance the development of HIV vaccines and other infectious disease products. The contract is a delivery order issued under an Indefinite...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the International AIDS Vaccine Initiative (IAVI), a non-profit organization. The contract has a total ceiling value of $4,687,192.00 and is a delivery order under IAVI's existing indefinite delivery/indefinite quantity (IDIQ) contract with NIAID for preclinical services supporting the development of biopharmaceutical products, including vaccines, for infectious diseases....
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $432,452.00 cost-plus-fixed-fee delivery order contract to the International AIDS Vaccine Initiative (IAVI), a non-profit organization, for a feasibility assessment of HIV envelope protein antigens. The contract does not have a set-aside designation. IAVI has conducted research, development, and advocacy to advance vaccines and antibodies for infectious...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $780,764 firm fixed price purchase order contract to Access To Advanced Health Institute, doing business as Aahi, Idri, Infectious Disease Research Institute, located in Rockville, Maryland. Under the contract, Idri will provide investigational products GLA-SE adjuvant formulation and lyophilized ID93 from Idri for clinical trials funded by NIAID's Division of AIDS. As the prime contractor, Idri will deliver the requested vaccine components to support NIAID's efforts to research and develop vaccines for infectious diseases like HIV/AIDS. No major subcontractors or set aside designations were indicated.

Generated 12/25/23, 1:43 AM